Seelos Therapeutics, Inc. - Company Profile
Powered by 
All the data and insights you need on Seelos Therapeutics, Inc. in one report.
$295
- Save hours of research time and resources with
our up-to-date Seelos Therapeutics, Inc. Strategy Report
- Understand Seelos Therapeutics, Inc. position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Seelos Therapeutics, Inc. (Seelos) is a clinical-stage biopharmaceutical company that focuses on developing novel technologies and therapeutics to address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company operates through one reportable segment which develops pharmaceutical products. It’s product pipeline includes SLS-002 (ketamine), SLS-004, SLS-005 (trehalose), SLS-006, SLS-007, SLS-008, SLS-010, and SLS-012. The company’s lead programs, SLS-002 (ketamine), an intranasal racemic ketamine in phase II clinical trials for treatment of acute suicidal ideation and behavior (ASIB) in major depressive disorder (MDD) and post-traumatic stress disorder (PSTD). SLS-005 (Trehalose), a protein stabilizer that crosses the blood-brain-barrier, activates autophagy and lysosomal biogenesis.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer